May 24, 2021

BioNTech to build mNR production plant in Singapore

BioNTech announced monday its goal of identifying a regional headquarters and building a new production plant for its messenger RNA (mRNA) vaccines in Singapore, as a component of the latest initiative to expand its production network. Singapore’s workplace in 2021 and the production site is expected to be operational until 2023, creating up to 80 jobs in Singapore. “Having nodes in our production network is a vital strategic step in building our global footprint and capabilities,” said Ugur Sahin, CEO and co-founder of BioNTech.

BioNTech to build mNR production plant in Singapore Read More »